The functional evaluation of dendritic cell vaccines based on different hepatitis C virus nonstructural genes

Viral Immunology

Volumn 20, Issue 4, 2007, Pages 553-561

  Tian, Yuan ^a   Zhang, Heng Hui ^a   Wei, Lai ^a   Du, Shao Cai ^a   Chen, Hong Song ^a   Fei, Ran ^a   Liu, Feng ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL VACCINE; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 4; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5A; NONSTRUCTURAL PROTEIN 5B;

ADENOVIRUS; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; EVALUATION; GENETIC CONSERVATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; LYMPHOCYTE; MONOCYTE; NONHUMAN; NORMAL HUMAN; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS IMMUNITY; VIRUS RECOMBINANT;

ADENOVIRIDAE; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANZYMES; HEPACIVIRUS; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-4; RECOMBINANT PROTEINS; VACCINES, DNA; VIRAL HEPATITIS VACCINES; VIRAL NONSTRUCTURAL PROTEINS;

ADENOVIRIDAE; HEPATITIS C VIRUS;

EID: 37549028770     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2007.0064     Document Type: Article

References (29)

1. Akbari O, Panjwani N, Garcia S, Tascon R, Lowrie D, and Stockinger B: DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J Exp Med 1999;189:169-178.
2. Alvarez-Obregon J, Duenas-Carrera S, Valenzuela C, and Grillo JM: A truncated HCV core protein elicits a potent immune response with a strong participation of cellular immunity components in mice. Vaccine 2001;19:3940-3946.
3. Cho JH, Lee SW, and Sung YC: Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization. Vaccine 1999; 17:1136-1144.
4. Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N, and Washabaugh MW: Memory T cells and vaccines. Vaccine 2003;21: 419-430.
5. Frelin L, Alheim M, Chen A, et al.: Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo. Gene Ther 2003;10: 686-699.
6. Gerlach JT, Diepolder HM, Jung MC, et al. : Recurrence of hepatitis C virus after loss of virus-specific CD4+ T cell response in acute hepatitis C. Gastroenterology 1999;117: 933-941.
7. Gruner NH, Gerlach TJ, Jung MC, et al.: Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 2000;181:1528-1536.
8. Jiao X, Wang RY, Qiu Q, Alter HJ, and Shih JW: Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by codelivery of protein antigen and CpG with cationic liposomes. J Gen Virol 2004;85:1545-1553.
9. Larsson M, Babcock E, Grakoui A, et al.: Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus. J Virol 2004;78:6151-6161.
10. Lauer GM, Ouchi K, Chung RT, et al.: Comprehensive analysis of CD8+-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol 2002;76: 6104-6113.
11. Li W, Li J, Tyrrell DL, Agrawal B: Expression of hepatitis C virus-derived core or NS3 antigens in human dendritic cells leads to induction of pro-inflammatory cytokines and normal T-cell stimulation capabilities. J Gen Virol 2006; 87:61-72.
12. Longman RS, Talal AH, Jacobson IM, Albert ML, and Rice CM: Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 2004; 103:1026-1029.
13. Mosmann TR, and Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-146.
14. Neumann-Haefelin C, Blum HE, Chisari FV, and Thimme R: T cell response in hepatitis C virus infection. J Clin Virol 2005;32:75-85.
15. Pancholi P, Perkus M, Tricoche N, Liu Q, and Prince AM: DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice. J Virol 2003; 77:382-390.
16. Qiao M, Murata K, Davis AR, Jeong SH, and Liang TJL: Hepatitis C virus-like particles combined with novel adjuvant systems enhance virus-specific immune responses. Hepatology 2003;37:52-59.
17. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, and Chisari FV: Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 1996;98:1432-1440.
18. Sarobe P, Lasarte JJ, Casares N, et al.: Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J Virol 2002;76:5062-5070.
19. Sarobe P, Lasarte JJ, Zabaleta A, et al.: Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J Virol 2003;77:10862-10871.
20. 51Cr-release assay for monitoring cell-mediated cytotoxicity. J Transl Med 2003;1:1-14.
21. Shoukry NH, Cawthon AG, and Walker CM: Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu Rev Microbiol 2004;58:391-424.
22. Timm J, Lauer GM, Kavanagh DG, et al.: CD8 epitope escape and reversion in acute HCV infection. J Exp Med 2004;200:1593-1604.
23. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, and Chisari FV: Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194:1395-1406.
24. Thomas DL: Hepatitis C epidemiology. Curr Top Microbiol Immunol 2000;242:25-41.
25. Ward S, Lauer G, Isba R, Walker B, and Klenerman P: Cellular immune responses against hepatitis C virus: the evidence base 2002. Clin Exp Immunol 2002;128:195-203.
26. Woodland DL, and Dutton RW: Heterogeneity of CD4+ and CD8+ T cells. Curr Opin Immunol 2003;15:336-342.
27. Xiang M, Eisenbach C, Lupu CM, Ernst E, Stremmel W, and Encke J: Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3. Viral Immunol 2006;19:210-219.
28. Yanagi M, St Claire M, Shapiro M, Emerson SU, Purcell RH, and Bukh J: Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. Virology 1998;244:161-172.
29. Yu H, Babiuk LA, and van Drunen Littel-van den Hurk S: Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA. Vaccine 2007;25:1701-1711.